Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer
暂无分享，去创建一个
[1] Q. Waisfisz,et al. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer , 2009, Breast Cancer Research and Treatment.
[2] Carl T Wittwer,et al. High‐resolution DNA melting analysis: advancements and limitations , 2009, Human mutation.
[3] Alison P. Klein,et al. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.
[4] R. Hruban,et al. Familial Pancreatic Cancer , 2018, Oncology Research and Treatment.
[5] M. Urioste,et al. Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families , 2009, Breast Cancer Research and Treatment.
[6] Hongbing Shen,et al. Association of Common PALB2 Polymorphisms with Breast Cancer Risk: A Case-Control Study , 2008, Clinical Cancer Research.
[7] J. Hopper,et al. Penetrance Analysis of the PALB2 c.1592delT Founder Mutation , 2008, Clinical Cancer Research.
[8] W. Foulkes,et al. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women , 2007, Breast Cancer Research.
[9] Hans Joenje,et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 , 2007, Nature Genetics.
[10] F. Couch,et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.